| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Marino Michael F III | Chief Legal Officer and Corporate Secretary | C/O NEWAMSTERDAM PHARMA COMPANY N.V., GOOIMEER 2-35, NAARDEN, NETHERLANDS | /s/ Louise Kooij by Power of Attorney from Michael F. Marino III | 03 Jun 2025 | 0001502700 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NAMS | Ordinary Shares | Award | +55,000 | 55,000 | 01 Jun 2025 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NAMS | Option (right to buy) | Award | $0 | +315,000 | $0.000000 | 315,000 | 01 Jun 2025 | Ordinary Shares | 315,000 | $18.11 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | Represents restricted stock units ("RSUs"), each representing a contingent right to receive one ordinary share. 1/3 of the RSUs will vest on each of the first, second and third anniversaries of the vesting start date, subject to the Reporting Person's continued service through each such date. |
| F2 | Each RSU was granted on June 1, 2025 for no consideration. |
| F3 | 25% of the shares underlying the option will vest on June 1, 2026, the one-year anniversary of the vesting start date, with the remaining shares vesting in equal monthly installments thereafter for three years, subject to the Reporting Person's continued service through each such date. |
Chief Legal Officer and Corporate Secretary